In our continuing efforts to discover novel bioactivities in rnicrobial metabolites, a new actinomycete strain isolated from a soil sample collected in Mindanao Island, the Philippines was found to produce a complexof newantiviral antibiotics, cycloviracin. The antibiotics were extracted from the fermentation broth with 1-butanol and purified by column chromatography. Two major components cycloviracins Bx and B2 have been isolated from the complex. They showed weak antimicrobial activity against Gram-positive bacteria and also antiviral activity against herpes simplex virus type 1 by both the plaque reduction assay and the dye uptake assay. This paper reports the fermentation, isolation, physico-chemical and biological properties of the antibiotics. The structure determination is reported in a separate paper1}. Production A small agar piece of the slant culture of Kibdelosporangium albatum sp. nov., strain R761-72) was inoculated into a 500-ml Erlenmeyer flask containing 100ml of the seed medium consisting of mashed potato 4%, corn steep liquor 2%, CaCO3 0.3% and NaCl 0.2% (the pH was adjusted to 8.0 before autoclaving). The seed culture was incubated at 28°C for 4 days on a rotary shaker (200rpm) and 5ml of the culture was transferred into a 500-ml Erlenmeyer flask containing 100 ml of the production medium having the same composition as the seed medium. The fermentation was carried out at 28°C for 6 days on a rotary shaker. The antibiotic production in the fermentation broth was monitored by the conventional cytopathic effect (CPE) assay using herpes simplex virus type 1 (KOS strain). The production reached a maximumafter 4 to 5 days fermentation, which showed the antiviral activity up to 48-fold broth dilution in terms of IC50 value.
Extraction and Purification The fermentation broth (20 liters, 50~100 /zg/ml) was stirred vigorously with 1-butanol (8 liters) for 30 minutes. The 1-butanol extract was concentrated in vacuo to dryness and the residue (9.0 g) was mixed with silica gel (25g) to adsorb the activity. This mixture was loaded on the top of a silica gel column Cycloviracins B1 and B2 were originally called BU-4224V Bx and B2, respectively.
(Wakogel C-200, 1.1 liters) which was developed with ethyl acetate -methanol -water (100 : 15 : 1) mixture. The eluate was collected in fractions (20ml) and each fraction was monitored by the antiviral assay and TLC(SiO2; EtOAc-MeOH-H2O, 10 : 3 : 1, H2SO4detection). The main active fractions were combined and concentrated in vacuo to give a crude mixture solid of cycloviracin (1.0 g).
The solid (1.0g) was dissolved in methanol (5ml) and applied on a reversed phase C18 column (YMC-ODS,AMtype, Yamamura Chem. Lab. Co., Ltd., 800ml). The column was developed with a 0.022 m phosphate buffer solution (pH 7.0) containing 45% acetonitrile (1.5 liters) and then with the buffer containing 50% acetonitrile (fr. 1~65). The presence of the antibiotics was detected by TLC (RP-18, . The first peak cuts containing cycloviracin B1 were combined and concentrated. The aqueous concentrate was extracted with 1-butanol and the extract was evaporated to yield a white solid ofcycloviracin Bx (54 mg). This was chromatographed on a column of Sephadex LH-20 (200ml) eluting with 90% aqueous methanol to afford a pure sample of cycloviracin B1 (48mg). The second peak cuts containing component B2 were worked up by a similar manner to yield a pure solid of cycloviracin B2 (49mg). SEPT. 1992 Physico-chemical Properties Cycloviracins Bt and B2 were soluble in methanol, pyridine and dimethyl sulfoxide, slightly soluble in ethyl acetate and acetone but practically insoluble in w-hexane, chloroform and water. They showed positive reactions to iodine and anthrone reagent but were negative to ninhydrin and Sakaguchi tests. The physico-chemical properties of cycloviracins Bj and B2 are summarized in Table 1 . Both compounds showedno absorption maximaabove 210 nm in the UVspectra. The molecular formulae of cycloviracins B1 and B2 were determined to be C83H152O33and C83H150O33, respectively, based on the microanalysis and negative FAB-MSdata. The IR spectra of cycloviracins Bl (Fig. 1) the drug-induced cytotoxicity were determined by means of the uptake of neutral red. ID50 was expressed as the concentration showing the 50%inhibition of the cytopathic effect of control, and TD50 was the concentration exhibiting the 50%cytotoxicity against Vero cells without viral infection. Acyclovir was used as a reference compound of anti-HSV activity. The antiviral activity of cycloviracins B1 and B2 was also evaluated by the conventional plaque reduction assay method using a 24-well microplate.
The results are shown in Table 2 . Both components demonstrated a potent antiviral activity against HSV-1 with ID50 values of 5^g/ml by the dye uptake assay, but its antiviral activity was less potent than that of acyclovir. In the plaque reduction assay, cycloviracins showedsomewhatweaker antiviral activity than that in the dye uptake assay.
Antimicrobial Activity The antimicrobial spectra of cycloviracins Bx and B2 against various bacteria and fungi are shown in Table 3 . MICswere determined by the agar dilution method using nutrient agar medium (Eiken) for aerobic bacteria and Sabouraud dextrose agar for fungi. The inoculum size was adjusted to 103~104 cfu/ml for aerobic bacteria and 106 cfu/ml for fungi. Cycloviracins B1 and B2 exhibited weak antibacterial activity against aerobic Gram-positive bacteria but did not show activity against aerobic Gram-negative bacteria and fungi.
